Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target.

Current Pharmaceutical Design
Vladimír KryštofRobert Fürst

Abstract

Deregulation of cyclin-dependent kinases (CDKs) has been associated with many cancer types and has evoked an interest in chemical inhibitors with possible therapeutic benefit. While most known inhibitors display broad selectivity towards multiple CDKs, recent work highlights CDK9 as the critical target responsible for the anticancer activity of clinically evaluated drugs. In this review, we discuss recent findings provided by structural biologists that may allow further development of highly specific inhibitors of CDK9 towards applications in cancer therapy. We also highlight the role of CDK9 in inflammatory processes and diseases.

Citations

Jan 9, 2013·Journal of Molecular Modeling·Jelena RandjelovićVladimir Savić
Jul 6, 2014·BioMed Research International·Lu-Lu ZhengPei Hao
Apr 29, 2014·Journal of Molecular Graphics & Modelling·Jelena RandjelovicVladimir Savic
Jan 15, 2016·Cell Cycle·Fatima Morales, Antonio Giordano
Jan 29, 2014·Arthritis & Rheumatology·Jasper H N YikDominik R Haudenschild
Sep 9, 2016·Expert Opinion on Investigational Drugs·Carmen Di GiovanniGiovanni Marzaro
Sep 24, 2016·Cancer Treatment Reviews·Rosaria ChilàGiovanna Damia
Oct 25, 2016·Future Medicinal Chemistry·Tinghan LiZhiyu Li
Sep 2, 2016·Endocrine-related Cancer·Muhammed H RahamanShudong Wang
Apr 21, 2017·Nucleic Acids Research·Maximilian F BlankIngrid Grummt
Feb 25, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Anna-Laura KretzJohannes Lemke
Jul 14, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Yebin LuWei Wei
Nov 10, 2018·Transcription·Matthew D GalbraithJoaquín M Espinosa
Dec 28, 2018·Blood·Elspeth M BeauchampLeonidas C Platanias
Apr 25, 2013·Nature Reviews. Cancer·Megan J BywaterRoss D Hannan
Feb 13, 2018·The Journal of Pharmacology and Experimental Therapeutics·Randy S SchrecengostCharles D Smith
Aug 10, 2019·Molecular Oncology·Muhammed H RahamanShudong Wang
Nov 12, 2016·Molecular BioSystems·Nikolas Ferreira Dos Santos PaparidisFernanda Canduri
Mar 16, 2019·Blood·Katherine L B Borden
Nov 2, 2017·Cell Division·Hana Paculová, Jiří Kohoutek
Aug 24, 2018·JCI Insight·Anisley ValenciagaMatthew D Ringel
Jun 4, 2020·Nature Communications·Carrow I WellsMatthew B Robers
Jul 1, 2020·Expert Opinion on Investigational Drugs·Toshihisa Satta, Steven Grant
Sep 17, 2020·Cell Death & Disease·Monika ŠtětkováStjepan Uldrijan
Aug 14, 2013·Molecular Cancer Therapeutics·Christine HaiderWolfgang Mikulits
Nov 9, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Justin CidadoLisa Drew
Jan 28, 2021·Signal Transduction and Targeted Therapy·Rui GongBenzhi Cai

❮ Previous
Next ❯

Methods Mentioned

BETA
two-hybrid
transfection
X-ray

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.